Alternatives to BeyondMD

Async-first compounded GLP-1 with a rarity for this list — free health coaching — at a flat one-price-all-doses rate. Fast and friendly up front; the strict, non-refundable fine print is the trade-off.

A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.

The async, needle-optional value play: oral or injectable semaglutide and tirzepatide from a low starting price, no video visit, ~3 days to a script — listed with its February 2026 FDA warning letter in plain view.

No video visit and no membership fee — semaglutide from $117.96/mo, tirzepatide from $178.98/mo — but Trava's own pages currently disagree with each other on its clinical-partner name and its cheapest semaglutide price.

FDA warning letter #721479 (Feb. 2026), which names joinbliv.com. An explicitly no-video-visit, fully async intake — as low as $116/mo semaglutide, $199/mo tirzepatide — with CareCredit and Klarna pay-later options, though state coverage isn't published.

Pepti publishes the lowest semaglutide price in this entire roster — $99 a month, flat at every titration dose, with the medication, physician review, shipping, refill management and unlimited messaging with your prescribing doctor all inside it. Tirzepatide is $199 on the same all-in, flat-at-every-dose basis. That number is low enough to deserve skepticism, so it is worth saying exactly where it comes from: Pepti states it on a dedicated cost page, repeats it in its FAQ ('we keep pricing flat and transparent at $99/mo all-in'), and prices the comparison against Hims, Henry Meds and Mochi on the same page. It names two prescribing physicians and says its medication is compounded by FDA-registered 503A or 503B pharmacies, though it never names which. The real limits are reach and format: it ships to 36 states rather than 50, it is cash-pay only and bills no insurance, and its needle-free oral GLP-1/GIP drops cost $349 — well above its own injection.

The lowest published prices here, on an open storefront with no account, email or intake in the way: microdose semaglutide $99 a month, standard semaglutide $129, microdose tirzepatide $119, standard tirzepatide $149, each once weekly with vitamin B6, plus needle-free oral drops of both molecules at the microdose price. The microdose tiers genuinely cost less than the standard ones, which is not true of every seller. Two things weigh against it. The oral drops carry no published evidence for the route, and milligrams by mouth are not interchangeable with milligrams injected. And the same page advertises retatrutide, badged "GLP-3", as coming soon alongside orforglipron and two oral tablets — retatrutide is investigational and approved for nothing, and "GLP-3" is a nickname rather than a drug class. No state list, no dispensing pharmacy named, and no time to first dose.

One of the few candidates verified this pass spanning both a cheap compounded entry ($99/mo semaglutide) and a real brand-name Wegovy/Zepbound fallback, billed once per plan rather than monthly — text-only consult, no video visit, but no stated turnaround time.

A LegitScript-certified compounded GLP-1 platform advertising $89/mo semaglutide and $139/mo tirzepatide — but those are first-month-only promos, the real recurring price is never published, and no turnaround time is stated.